HIGHFDA DEVICE

CorNeat Vision EverPatch 1036295 Recall for Labeling Update in 2024

CorNeat Vision recalled EverPatch surgical matrix (REF 1036295) in a worldwide distribution that includes 50 states and several countries. The recall addresses retroactive labeling corrections to include prevention and management of would dehiscence. Healthcare providers and patients should stop using the device and follow the manufacturer's recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
October 16, 2024
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
October 16, 2024
Hazard Level
HIGH
Brand
CorNeat Vision
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
CorNeat Vision
Product type
Permanent Tissue-Integrating Surgical Matrix
Model numbers
G16010362950
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    October 16, 2024

  2. Reported by FDA DEVICE

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Retroactive; Due to complaints, labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of would dehiscence.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact CORNEAT VISION, LTD. or your healthcare provider for instructions. Notification method: E-Mail

About This Product

EverPatch is a sterile, prescription-only surgical matrix used to support tissue healing. It measures 5.0 mm x 6.5 mm x 100 μm.

Why This Is Dangerous

The recall is retroactive and centers on labeling to include prevention and management of would dehiscence.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

The recall may affect procurement and labeling workflows for procedures that use EverPatch; the data does not indicate injuries from the device itself.

Practical Guidance

How to identify if yours is affected

  1. Check packaging and documentation for REF 1036295 and UDI-DI G16010362950
  2. Confirm the device is EverPatch permanent tissue-integrating surgical matrix
  3. Note that product is prescription-only (RX) and SterileEO
  4. If in doubt, contact your healthcare provider or CORNEAT VISION, LTD.

Where to find product info

FDA enforcement report: Z-2537-2025 page linked in recall notice

What timeline to expect

Timeline for refund or replacement is not specified by the manufacturer

If the manufacturer is unresponsive

  • Escalate with your hospital or surgical center's safety office
  • Contact FDA or CPSC if the company is unresponsive
  • Document all communications and retain copies of the recall notice

How to prevent similar issues

  • Verify labeling for dehiscence prevention guidance in future devices
  • Ask suppliers to confirm updated labeling before use
  • Monitor for updates from CORNEAT VISION, LTD. and the FDA recall page

Documentation advice

Retain the recall notice, packaging, serial/UDI, and correspondence with the manufacturer or healthcare provider

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: UDI-DI: G16010362950. Sold worldwide, including US states listed in the recall and countries Argentina, Israel, and Hong Kong. When sold: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Worldwide distribution; US states listed plus Argentina, Israel, Hong Kong
  • Retroactive labeling correction to prevent dehiscence
  • Package indicates SterileEO; RX only
  • Active recall as of 2024-10-16; reported 2025-09-17

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
G16010362950
Affected States
ALL
Report Date
September 17, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more